AzTrials
AzTrials

Knee OsteoarthritisNCT04321356

Analysis of Competitive Posterior Cruciate Retaining (PCR) and Posterior Stabilized (PS) Total Knee Arthroplasty (TKA)

An observational study of Knee Osteoarthritis and Total Knee Arthroplasty, run by The University of Tennessee, Knoxville at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study is to acquire kinematic in vivo fluoroscopy data from subjects who were implanted with Stryker Posterior Cruciate Retaining (PCR) , Stryker Posterior Stabilized (PS), Zimmer PCR, and Zimmer PS Total Knee Arthroplasty (TKAs). Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Knee Osteoarthritis, Total Knee Arthroplasty, Knee
What is being tested?
Triathlon PCR TKA, Triathlon PS TKA and Persona PCR TKA
Type of treatment
Medical device
How many people
100 participants
Where
2 sitesUnited States
Study dates
24 Feb 2020to 16 May 2022
Phase
Observational
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients implanted with a Stryker Triathlon PCR, Stryker Triathlon PS, Zimmer Persona PCR, or Zimmer Persona PS total knee arthroplasty (TKA) implanted by Dr. Harold E. Cates.

Who may be able to join

  • Subjects will have one of the following implant types: 1) Stryker Triathlon PCR TKA (28 subjects), 2) Stryker Triathlon PS TKA (28 subjects), 3) Zimmer Persona PCR TKA (28 subjects) and 4) Zimmer Persona PS TKA (28 subjects).
  • Patients must be at least three months post-operative.
  • Participants must not experience any pain or other post-operative complications.
  • Participants must have a stable TKA and be capable of performing a deep knee bend activity.
  • Participants must weigh less than 300 lbs., not underweight (BMI < 18.5) or too obese (BMI>35).
  • Must be in the age range of 18 years to 85 years (both inclusive).
Show all 9Show fewer
  • Participants must be able to perform the required activities without concern.
  • Subjects must be willing to sign the Informed Consent (IC) form to participate in the study.
  • Patients who do not have previous surgery on the implanted knee that might restrict their movement.

Who cannot join

  • Pregnant, potentially pregnant, lactating females or of childbearing age. To satisfy radiation protocol, each female subject will be asked if she is pregnant, or possibly could be pregnant. A pregnant person will not be allowed to participate in the study. (All potential female study patients will be asked if they are premenopausal or if they have undergone a hysterectomy. If the possibility of pregnancy exists, a pregnancy kit will be given to the patient at the informed consent meeting, just prior to the fluoro. Results of the test will be recorded in a test log. Any female patient showing a positive test will be excluded from testing.)
  • Subjects without the required type of knee implant.
  • Cannot have pain in other parts of the body that would prohibit the subject from performing the activities).
  • Cannot have ligamentous pain and/or laxity.
  • Unwilling to sign IC/HIPAA form(s).
  • Does not speak English.
Show all 10Show fewer
  • Patients who have enrolled in a fluoroscopic kinematic study within the past year.
  • Patients currently involved in any personal injury litigation, medical/legal or worker's compensation claims.
  • Patients with known drug or alcohol abuse histories or psychological disorders that could affect ability to complete all aspects of the study.
  • Patients with neurological or musculoskeletal disorders that might adversely affect weight-bearing motion ability.

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Tennessee Orthopaedic Clinic

    Knoxville, Tennessee, 37923

  • The University of Tennessee

    Knoxville, Tennessee, 37996

Other trials in United States

About this study

Official title: Analysis of Competitive PCR and PS Total Knee Arthroplasty

The purpose of the study is to acquire kinematic in vivo fluoroscopy data from subjects who were implanted with Stryker Posterior Cruciate Retaining (PCR) , Stryker Posterior Stabilized (PS), Zimmer PCR, and Zimmer PS Total Knee Arthroplasty (TKAs). Our lab has previously collected data for the Smith \& Nephew PCR, bi-cruciate retaining (BCR), and bi-cruciate stabilized (BCS) TKA.

Read the detailed description

The objective for this study is to analyze the in vivo kinematics for subjects implanted with either a Stryker PCR, Stryker PS, Zimmer PCR, and Zimmer PS TKA and to compare those patterns to subjects having a normal knee from our previous study and to those patterns from subjects having a Smith \& Nephew PCR, BCR, and BCS TKA.

Being tested
Triathlon PCR TKA, Triathlon PS TKA, Persona PCR TKA, Persona PS TKA
Keywords
Total Knee Arthroplasty
Medical subject headings
Osteoarthritis, Knee

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Triathlon PCR TKADevice

    Total Knee Arthroplasty System

  • Triathlon PS TKADevice

    Total Knee Arthroplasty System

  • Persona PCR TKADevice

    Total Knee Arthroplasty System

  • Persona PS TKADevice

    Total Knee Arthroplasty System

Study groups in NCT04321356
Study groupRoleWhat they receive
Stryker Triathlon PCR TKASubjects implanted with a Stryker Triathlon PCR TKA
Receives: Device: Triathlon PCR TKA
Stryker Triathlon PS TKASubjects implanted with a Stryker Triathlon PS TKA
Receives: Device: Triathlon PS TKA
Zimmer Persona PCR TKASubjects implanted with a Zimmer Persona PCR TKA
Receives: Device: Persona PCR TKA
Zimmer Persona PS TKASubjects implanted with a Zimmer Persona PS TKA
Receives: Device: Persona PS TKA

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Medial AP Translations, in mm, During Deep Knee Bend (DKB) Activity

    Anterior Posterior (AP) translations, in mm, of medial femoral condyle during deep knee bend activity. Positive values indicate anterior motion of the medial femoral condyle, and negative values indicate posterior motion of the medial femoral condyle.

    Measured: 3 months post-operative

  2. Lateral AP Translations, in mm, During Deep Knee Bend (DKB) Activity

    Anterior Posterior (AP) translations, in mm, of lateral femoral condyle during deep knee bend activity. Positive values indicate anterior motion of the lateral femoral condyle, and negative values indicate posterior motion of the lateral femoral condyle.

    Measured: 3 months post-operative

  3. Maximum Flexion, in Degrees, During Deep Knee Bend Activity

    Maximum weight-bearing flexion, in degrees, during deep knee bend activity

    Measured: 3 months post-operative

  4. Axial Rotation, in Degrees, During Deep Knee Bend Activity

    Axial rotation (AR), in degrees, during deep knee bend activity. Positive values indicate external femorotibial axial rotation, and negative values indicate internal femorotibial axial rotation.

    Measured: 3 months post-operative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Mar 2020
  2. Study start24 Feb 2020
  3. Primary completion16 May 2022
  4. Study completion16 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04321356
Sponsor's protocol ID
3187FB WIRB20180745 Extension
Status last verified
Feb 2023
First submitted
19 Dec 2019
Last updated
28 Nov 2023
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No: Researchers would like to retain this study data in our secure database so as to continue to add relevant, current data to our digital collection to help us work with manufacturers in the future to create better implants that last longer and will not require revision surgery. Participants will be asked if their study data may remain a part of the University of Tennessee's Center for Musculoskeletal Research data collection for use in future studies in the IC. Identifiers are automatically removed from the database upon entry into the secure server. Data shared with sponsors is de-identified.

Questions about this trial

What is this clinical trial studying?

An observational study of Knee Osteoarthritis and Total Knee Arthroplasty, run by The University of Tennessee, Knoxville at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 28 Nov 2023). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Medial AP Translations, in mm, During Deep Knee Bend (DKB) Activity (time frame: 3 months post-operative). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT04321356 | AzTrials